ReviewCardiovascular toxicology2026
A Bibliometric Review and Knowledge Mapping of Microplastics and Nanoplastics in Cardiovascular Research.
Review in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microplastics and nanoplastics (MNPs) have been detected in human blood and cardiovascular tissues, raising concerns about their potential role in cardiovascular disease (CVD). However, the overall research landscape-including knowledge structure, collaboration networks, and evolving trends-remains poorly characterized. This study aims to map the field using bibliometric analysis. Publications from 2017 to 2025 were retrieved from the Web of Science Core Collection. Bibliometric analyses (publication trends, country/institution collaboration networks, keyword co-occurrence and clustering, co-citation networks, and burst detection) were performed using CiteSpace, VOSviewer, and Scimago Graphica. A total of 390 publications were analyzed. Annual publication output has grown exponentially since 2022. China, the United States, and Italy are the core contributing countries. Research hotspots center on inflammatory responses, oxidative stress, and pollutant exposure. The frontier has shifted from fundamental toxicology toward nanoplastics and specific polymers (e.g., polystyrene) in CVD, as well as their association with clinical outcomes. Emerging foci include cardio-renal comorbidity. To our knowledge, this is the first bibliometric study to systematically map the MNP-CVD research field. The field is moving from mechanistic exploration toward clinical epidemiological research. Future priorities include interdisciplinary collaboration, standardized detection methods, large-scale prospective cohort studies, and mechanism-based targeted interventions. Bibliometric data reflect publication patterns, not causal evidence.
Indexed as
Identifiers
42201430What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.